Exhibit 99.1
Schedule A
Capitalized terms used but not defined in this Schedule A shall have the meanings set forth in the Schedule 13D of which this Schedule A is an exhibit. The following table sets forth the name, position, address, principal occupation and citizenship or jurisdiction of each executive officer and director of the Reporting Person:
| Name (Position with Reporting Person) | Principal Occupation | Citizenship | Business Address | Number and Percentage of Shares of Issuer Common Stock Owned (1)(2) | Transactions during the past 60 days |
| Kenneth Sim, M.D. (Chairman and Director) | Executive Chairman of Issuer | United States | 1668 S. Garfield Ave., 2nd Floor Alhambra, CA 91801 | 1,488,942 (2.66%)(3) | (5) |
| Thomas Lam, M.D. (Chief Executive Officer, Chief Financial Officer and Director) | Vice Chair and Director of Issuer | United States | 1668 S. Garfield Ave., 2nd Floor Alhambra, CA 91801 | 1,631,565 (2.91%)(4) | (5) |
| Paul Liu, M.D. (Director) | Physician | United States | 2233 Huntington Dr., #10 San Marino, CA 91108 | 1,625,344 (2.90%) | (5) |
| Paul Chu, M.D. (Chief Medical Officer and Director) | Physician | United States | 945 N. Hill Street Los Angeles, CA 90012 | 160,297 (0.29%) | (5) |
| Albert Young, M.D. (Senior Executive Vice President and Director) | Senior Vice President of Health Affairs of Issuer | United States | 1668 S. Garfield Ave., 2nd Floor Alhambra, CA 91801 | 1,198,416 (2.14%) | (5) |
| Dennis Chan, M.D. (Director) | Physician | United States | 120 W. Hellman Ave., #201 Monterey Park, CA 91754 | 1,528,455 (2.73%) | (5) |
| Lei Ding, M.D. (Director) | Physician | United States | 1661 Hanover Rd., #101 City of Industry, CA 91748 | 143,778 (0.26%) | (5) |
| Pen Hong Lee, M.D. (Director) | Physician | United States | 600 N. Garfield Ave., #110 Monterey Park, CA 91754 | 1,239,380 (2.22%) | (5) |
| Su Kin Lee, M.D. (Director) | Physician | United States | 1418 S San Gabriel Blvd., #C San Gabriel, CA 91776 | 1,575,886 (2.82%) | (5) |
| Peter Ma, M.D. (Director) | Physician | United States | 624 W. Duarte Rd., #208 Arcadia, CA 91007 | 5,617 (0.01%) | (5) |
| Lakhi Sakhrani, M.D. (Interim Corporate Secretary and Director) | Physician | United States | 333 S. Garfield Ave., 2nd Floor #H Alhambra, CA 91801 | 1,936,153 (3.46%) | (5) |
| Nora Tee, M.D. (Director) | Physician | United States | 841 W. Valley Blvd., #107 Alhambra, CA 91803 | 476,518 (0.85%) | (5) |
| Theresa Tseng, M.D. (Director) | Physician | United States | 1153 S. Garfield Ave. Alhambra, CA 91801 | 1,473,484 (2.63%) | (5) |
| Wei Wang, M.D. (Director) | Physician | United States | 223 N. Garfield Ave., #208 Monterey Park, CA 91754 | 109,915 (0.20%) | (5) |
| Wan Yao, M.D. (Director) | Physician | United States | 228 N. Garfield Ave., #302 Monterey Park, CA 91754 | 128,631 (0.23%) | (5) |
| (1) | Does not include any shares of Common Stock held by the Reporting Person. |
| (2) | The percentage ownership of shares of Common Stock set forth in this table is based on 56,252,730 shares of Common Stock reported by the Issuer as outstanding as of November 6, 2024 in the Issuer’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2024 (which includes shares held by the Reporting Person, which are treated by the Issuer as treasury shares for accounting purposes), minus 300,000 shares of Common Stock repurchased by the Issuer from the Reporting Person on January 17, 2025. Except as indicated by the footnotes below, the Reporting Person believes that the persons named in the table have sole voting and dispositive power with respect to all shares of the Issuer’s Common Stock that they beneficially own, subject to applicable community property laws. |
| (3) | Dr. Sim directly holds 609,905 shares of Common Stock and options to purchase 59,004 shares of Common Stock that are exercisable within 60 days of the filing of this Statement and may be deemed to beneficially own 42,996 shares of Common Stock held by the Kenneth T. Sim Pension Plan Trust U.A. dated 12/18/2007, 230,688 shares of Common Stock held by a grantor retained annuity trust for the benefit of Dr. Sim and his children, and 546,349 shares of Common Stock held by the Kenneth T & Simone S Sim Family Trust U/A dated 11/07/2013. Dr. Sim disclaims beneficial ownership of the shares held by such trusts except to the extent of his pecuniary interest therein. |
| (4) | Dr. Lam directly holds 438,855 shares of Common Stock and options to purchase 59,004 shares of Common Stock that are exercisable within 60 days of the filing of this Statement and may be deemed to beneficially own 1,133,706 shares of Common Stock held by the Thomas and Jeanette Lam 2002 Family Trust U/A dated 09/06/2002. Dr. Lam disclaims beneficial ownership of the shares held by such trust except to the extent of his pecuniary interest therein. |
| (5) | Each of the officers and directors listed in this table are also stockholders of the Reporting Person and, accordingly, each received shares of the Common Stock pursuant to the pro rata distribution for no consideration of Common Stock by the Reporting Person on February 15, 2025. The table below provides the number of shares received by each individual in the distribution: |
| Name | Shares of Issuer Common Stock Received in the Distribution |
| Kenneth Sim, M.D. | 26,232 |
| Thomas Lam, M.D. | 26,232 |
| Paul Liu, M.D. | 20,919 |
| Paul Chu, M.D. | 11,297 |
| Albert Young, M.D. | 13,667 |
| Dennis Chan, M.D. | 24,834 |
| Lei Ding, M.D. | 11,113 |
| Pen Hong Lee, M.D. | 23,077 |
| Su Kin Lee, M.D. | 20,794 |
| Peter Ma, M.D. | 5,617 |
| Lakhi Sakhrani, M.D. | 12,860 |
| Nora Tee, M.D. | 10,915 |
| Theresa Tseng, M.D. | 23,484 |
| Wei Wang, M.D. | 9,915 |
| Wan Yao, M.D. | 5,631 |
